World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
44
Citations
17791
World Ranking
5070
National Ranking
64

Mauro Schechter publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Mauro Schechter sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 84 publications — 2nd percentile

2% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Mauro Schechter D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Mauro Schechter sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 44 D-Index — 8th percentile

8% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Mauro Schechter is affiliated with the Federal University of Rio de Janeiro in Brazil and has contributed extensively to medical research, particularly in the fields of HIV and infectious diseases. Their scholarly work spans multiple disciplines including Medicine and Immunology and Microbiology, with a focus on several subfields such as Virology, Infectious Diseases, Molecular Biology, Pediatrics, Perinatology and Child Health, and Epidemiology.

Their research primarily addresses issues related to HIV research and treatment, including HIV/AIDS drug development and treatment protocols. Other significant topics of investigation include poxvirus research and outbreaks, studies on Bacillus and Francisella bacterial species, pharmacological effects and toxicity studies, herpesvirus infections and treatments, and broader viral infections and outbreak research.

Mauro Schechter's frequent coauthors include Jürgen K. Rockstroh, Bonaventura Clotet, José Luís Blanco, Alexandra Calmy, and Laura Waters. This network of collaborators points to a strong presence within international research communities focusing on infectious diseases and virology.

The scientist's publications are distributed among several notable venues, reflecting the multidisciplinary nature of their work. Their most common publication outlet is UNC Libraries, followed by contributions to The Lancet, Clinical Infectious Diseases, Journal of Virus Eradication, and PLOS Global Public Health.

Recent papers by Mauro Schechter include the following:

  • Mpox in people with advanced HIV infection: a global case series, 2023, The Lancet
  • Geographical Differences in the Self-Reported Functional Impairment of People With Human Immunodeficiency Virus (HIV) and Associations With Cardiometabolic Risk, 2022, Clinical Infectious Diseases
  • Impact of interrupting antiretroviral therapy started during primary HIV-1 infection on plasma neurofilament light chain protein, a marker of neuronal injury: The SPARTAC trial, 2024, Journal of Virus Eradication
  • International healthcare workers' experiences and perceptions of the 2022 multi-country mpox outbreak, 2025, PLOS Global Public Health
  • Subgroup and Resistance Analyses of Raltegravir for Resistant HIV-1 Infection, 2020, UNC Libraries

Best Publications

  • Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men

    Robert M. Grant;Javier R. Lama;Peter L. Anderson;Vanessa McMahan

  • Antiretroviral Therapy in Adults: Updated Recommendations of the International AIDS Society–USA Panel

    Charles C. J. Carpenter;David A. Cooper;Margaret A. Fischl;Jose M. Gatell

  • Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study

    Robert M. Grant;Robert M. Grant;Robert M. Grant;Peter L. Anderson;Vanessa McMahan;Albert Liu

  • Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries.

    P Braitstein;Mwg Brinkhof;F Dabis;M Schechter

  • Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men.

    Peter L. Anderson;David V. Glidden;Albert Liu;Susan Buchbinder

  • Treatment for adult HIV infection : 2006 recommendations of the international AIDS society-USA panel

    Scott M. Hammer;Michael S. Saag;Mauro Schechter;Julio S. G. Montaner

  • Antiretroviral Treatment for Adult HIV Infection in 2002: Updated Recommendations of the International AIDS Society-USA Panel

    Patrick G. Yeni;Scott M. Hammer;Charles C. J. Carpenter;David A. Cooper

  • Raltegravir with Optimized Background Therapy for Resistant HIV-1 Infection

    Roy T. Steigbigel;David A. Cooper;Princy N. Kumar;Joseph E. Eron

  • Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel.

    Patrick G. Yeni;Scott M. Hammer;Martin S. Hirsch;Michael S. Saag

  • Subgroup and resistance analyses of raltegravir for resistant HIV-1 infection.

    David A. Cooper;Roy T. Steigbigel;Jose M. Gatell;Jurgen K. Rockstroh

  • Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs.

    Frederick L Altice;Frederick L Altice;Adeeba Kamarulzaman;Vincent V Soriano;Mauro Schechter

  • Advancing global health and strengthening the HIV response in the era of the Sustainable Development Goals: the International AIDS Society-Lancet Commission

    Linda Gail Bekker;Linda Gail Bekker;George Alleyne;Stefan Baral;Javier Cepeda

  • Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries

    Martin W. G. Brinkhof;François Dabis;Landon Myer;David R. Bangsberg

  • Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general population.

    Alison J. Rodger;Rebecca Lodwick;Mauro Schechter;Steven Deeks

  • Rifampin and Pyrazinamide vs Isoniazid for Prevention of Tuberculosis in HIV-Infected Persons: An International Randomized Trial

    F Gordin;R E Chaisson;J P Matts;C Miller

  • Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society--USA panel.

    Scott M Hammer;Michael S Saag;Mauro Schechter;Julio S G Montaner

  • HIV-1 DNA predicts disease progression and post-treatment virological control

    James P Williams;Jacob Hurst;Jacob Hurst;Wolfgang Stöhr;Nicola Robinson;Nicola Robinson

  • Nevirapine and efavirenz elicit different changes in lipid profiles in antiretroviral-therapy-naive patients infected with HIV-1.

    Frank van Leth;Prahpan Phanuphak;Erik Stroes;Brian Gazzard

  • Behavioral Impact, Acceptability, and HIV Incidence among Homosexual Men with Access to Postexposure Chemoprophylaxis for HIV

    Mauro Schechter;Regina F. Do Lago;Aaron B. Mendelsohn;Ronaldo I. Moreira

  • Long-term efficacy and safety of Raltegravir combined with optimized background therapy in treatment-experienced patients with drug-resistant HIV infection: week 96 results of the BENCHMRK 1 and 2 Phase III trials

    Roy T. Steigbigel;David A. Cooper;Hedy Teppler;Joseph J. Eron

  • Manual de HIV/AIDS

    Marcia Rachid;Mauro Schechter

  • Efficacy and safety of etravirine in treatment-experienced, HIV-1 patients: pooled 48 week analysis of two randomized, controlled trials.

    Christine Katlama;Richard Haubrich;Jacob Lalezari;Adriano Lazzarin

  • Long-term immunologic response to antiretroviral therapy in low-income countries: a collaborative analysis of prospective studies.

    Denis Nash;Monica Katyal;Martin W.G. Brinkhof;Olivia Keiser

  • Immunological biomarkers predict HIV-1 viral rebound after treatment interruption

    Jacob Hurst;Matthias Hoffmann;Matthew Pace;Matthew Pace;James P. Williams

  • Effects of Emtricitabine/Tenofovir on Bone Mineral Density in HIV-Negative Persons in a Randomized, Double-Blind, Placebo-Controlled Trial

    Kathleen Mulligan;David V. Glidden;Peter L. Anderson;Albert Liu

  • Community-based interventions to improve and sustain antiretroviral therapy adherence, retention in HIV care and clinical outcomes in low- and middle-income countries for achieving the UNAIDS 90-90-90 targets

    Jean B. Nachega;Jean B. Nachega;Jean B. Nachega;Olatunji Adetokunboh;Olalekan A. Uthman;Olalekan A. Uthman;Amy W. Knowlton

Frequent Co-Authors

Lee H. Harrison
Lee H. Harrison University of Pittsburgh
Robert M. Grant
Robert M. Grant University of California, San Francisco
David A. Cooper
David A. Cooper University of New South Wales
Matthias Egger
Matthias Egger University of Bern
Linda-Gail Bekker
Linda-Gail Bekker University of Cape Town
François Dabis
François Dabis University of Bordeaux
David V. Glidden
David V. Glidden University of California, San Francisco
Kenneth H. Mayer
Kenneth H. Mayer Harvard Medical School
Susan Buchbinder
Susan Buchbinder University of California, San Francisco
Paula Braitstein
Paula Braitstein University of Toronto

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring careers related to Microbiology often includes options in healthcare administration and medical coding. For those interested in healthcare documentation and coding, earning a cpc certification salary reflects the growing demand for certified professional coders. This credential can open doors to stable and rewarding career paths within medical billing and health information management.

Health Information Management (HIM) is another promising field, combining data management with healthcare expertise. An essential step is choosing a cahiim accredited him degree online, which ensures your education meets industry standards and increases employability. Graduates often find competitive roles with attractive health information management degree salary prospects.

For those seeking a quicker entry into the field, a fast track medical billing and coding certificate online program can be an efficient way to build foundational skills. These accelerated options provide valuable credentials that help jumpstart a career in medical billing, coding, and health information processing—fields closely linked to microbiology in healthcare environments.

Best Scientists Citing Mauro Schechter

Trending Scientists